Being tested
Tenofovir alafenamide: protect nerve tissue in MS (type not specified)
MS (type not specified) · Antiviral / EBV-targeting
Trials are running now and no controlled trial has a readable result yet.
- Trials
- 1
- Running now
- 1
- Controlled phase 2/3 trials
- 1
- People in controlled trials
- 61
How the verdict was reached
No result yet
| Trial | Phase | Participants | Started | Result | Counted |
|---|---|---|---|---|---|
| Tenofovir alafenamide, phase 2 | Phase 2 | 61 | 2026 | Still running | Will count when it reports |
Counted: 0. Will count later: 1. Not counted: 0.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- Oct 2026First listed as Being tested
Related hypotheses
Assembled by software from public sources.